Laman UtamaYPHDF • OTCMKTS
add
Ypsomed Holding AG
Tutup sebelumnya
$392.02
Julat tahun
$362.28 - $535.75
Permodalan pasaran
4.59B CHF
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
SWX
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (CHF) | Sep 2025info | Perubahan T/T |
|---|---|---|
Hasil | 181.34J | 11.94% |
Perbelanjaan pengendalian | -8.52J | -120.75% |
Pendapatan bersih | 69.55J | 326.67% |
Margin untung bersih | 38.35 | 281.21% |
Pendapatan bagi setiap syer | — | — |
EBITDA | 102.22J | 132.33% |
Kadar cukai berkesan | 5.55% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (CHF) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 36.30J | -30.61% |
Jumlah aset | 1.21B | 2.35% |
Jumlah liabiliti | 401.49J | -28.19% |
Jumlah ekuiti | 807.19J | — |
Syer tertunggak | 13.65J | — |
Harga kepada buku | 6.63 | — |
Pulangan pada aset | 17.29% | — |
Pulangan pada modal | 25.58% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (CHF) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 69.55J | 326.67% |
Tunai daripada operasi | 65.19J | 94.90% |
Tunai daripada pelaburan | 78.74J | 222.01% |
Tunai daripada pembiayaan | -143.68J | -791.74% |
Perubahan bersih dalam tunai | -97.00K | 99.11% |
Aliran tunai bebas | -3.03J | 91.47% |
Perihal
Ypsomed Holding Inc. is a Swiss multinational medical technology company headquartered in Burgdorf, Switzerland. Founded in 2003, through the break up of Disetronic Group, founded by Willy Michel. Ypsomed specializes in developing and manufacturing injection and infusion systems for self-medication, primarily in the areas of diabetes care and biotechnology.
Products include devices like insulin pens, auto-injectors, and infusion pumps, which help patients manage chronic conditions more easily and independently. In 2025, Ypsomed employs 2,800+ employees and has an annual turnover of 728.9 million Swiss Francs. The company is listed on SIX Swiss Exchange. Wikipedia
CEO
Diasaskan
2003
Tapak web
Pekerja
2,000
